ARIAD Pharmaceuticals, Inc. operates as a global oncology firm, dedicated to the identification, advancement, and commercialization of innovative therapies. Its core mission is to significantly improve the lives of those affected by cancer. Leveraging an innovative methodology grounded in structure-based drug design, the company has successfully pioneered numerous precision-targeted treatments, particularly addressing malignancies that are resistant to existing therapies or are inherently challenging to manage.